跳至主要内容
临床试验/IRCT138902241556N14
IRCT138902241556N14已完成2 期

The effect of Granisetron on negative symptoms in patients with chronic schizophrenia: a double blind and placebo controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Inclusion Criteria: Age between 18-55, Diagnosis of Schizophrenia based on DSM IV; chronic Schizophrenia, at leats four weeks treatment with rispreidone and a stable positive symptom

排除标准

  • 1- Substance dependence,2- IQ <70,3-any other mental disorder on axis I, 4-Any serious medical or neurological problem ,5- receiving oral antipsychotic medications during the last week or receiving any depot antipsychotic medication during the last month,6- receiving ECT during the last 14 days

研究者

相似试验